The European Smaller Companies Trust (LON:ESCT) Stock Jumps 1.1% – Still a Buy?
by Michael Walen · The Markets DailyThe European Smaller Companies Trust PLC (LON:ESCT – Get Free Report) shares were up 1.1% during trading on Wednesday. The stock traded as high as GBX 223.50 and last traded at GBX 223.50. Approximately 1,161,570 shares were traded during trading, an increase of 19% from the average session volume of 972,415 shares. The stock had previously closed at GBX 221.
The European Smaller Companies Trust Price Performance
The company’s 50-day moving average price is GBX 233.36 and its 200-day moving average price is GBX 232.70. The company has a quick ratio of 0.04, a current ratio of 0.07 and a debt-to-equity ratio of 9.38. The firm has a market cap of £757.71 million, a price-to-earnings ratio of 6.24 and a beta of 1.28.
The European Smaller Companies Trust (LON:ESCT – Get Free Report) last issued its quarterly earnings results on Wednesday, September 30th. The company reported GBX 5.30 earnings per share for the quarter. The European Smaller Companies Trust had a return on equity of 13.22% and a net margin of 92.80%.
Insider Activity
In other news, insider Kate Cornish Bowden purchased 459 shares of the company’s stock in a transaction that occurred on Tuesday, September 8th. The shares were purchased at an average price of GBX 240 per share, for a total transaction of £1,101.60. Insiders own 0.08% of the company’s stock.
The European Smaller Companies Trust Company Profile
The Company’s investment objective is to achieve capital growth by investing predominantly in smaller and medium sized companies in Europe. The Company maintains a diversified portfolio. The Company invests 7% of its total assets. The Company invests in equities and other investments for long term, so as to secure its investment objective.
Read More
- Five stocks we like better than The European Smaller Companies Trust
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors